Chemoinformaics analysis of 6-Benzoyl-12-methyl-13-oxo-9(12)-9(12)-dihomo-18-podocarpanol
| Molecular Weight | 424.581 | nRot | 3 |
| Heavy Atom Molecular Weight | 388.293 | nRig | 27 |
| Exact Molecular Weight | 424.261 | nRing | 5 |
| Solubility: LogS | -4.818 | nHRing | 0 |
| Solubility: LogP | 4.123 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 72.3026 |
| nHD | 1 | BPOL | 39.5875 |
| QED | 0.679 |
| Synth | 5.596 |
| Natural Product Likeliness | 2.517 |
| NR-PPAR-gamma | 0.646 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.769 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.992 |
| MDCK | 0.0000234 |
| BBB | 0.344 |
| PPB | 0.993536 |
| VDSS | 0.955 |
| FU | 0.0253143 |
| CYP1A2-inh | 0.054 |
| CYP1A2-sub | 0.276 |
| CYP2c19-inh | 0.333 |
| CYP2c19-sub | 0.868 |
| CYP2c9-inh | 0.425 |
| CYP2c9-sub | 0.378 |
| CYP2d6-inh | 0.207 |
| CYP2d6-sub | 0.135 |
| CYP3a4-inh | 0.907 |
| CYP3a4-sub | 0.42 |
| CL | 7.531 |
| T12 | 0.739 |
| hERG | 0.697 |
| Ames | 0.009 |
| ROA | 0.014 |
| SkinSen | 0.829 |
| Carcinogencity | 0.109 |
| EI | 0.414 |
| Respiratory | 0.426 |
| NR-Aromatase | 0.36 |
| Antiviral | Yes |
| Prediction | 0.874679 |